We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+10.38%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$16.6B
AUM Growth
+$973M
Cap. Flow
-$466M
Cap. Flow %
-2.8%
Top 10 Hldgs %
30.85%
Holding
337
New
11
Increased
98
Reduced
190
Closed
11

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$43.9M
2
DELL icon
Dell
DELL
+$36.8M
3
CME icon
CME Group
CME
+$29.7M
4
AFG icon
American Financial Group
AFG
+$18.4M
5
WMB icon
Williams Companies
WMB
+$16.6M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$49.2M
2
AVGO icon
Broadcom
AVGO
+$43.2M
3
UPS icon
United Parcel Service
UPS
+$26.7M
4
PLD icon
Prologis
PLD
+$26.4M
5
ABT icon
Abbott
ABT
+$26M

Sector Composition

Rank Sector Weight
1 Technology 22.48%
2 Healthcare 14.22%
3 Financials 13.06%
4 Industrials 12.03%
5 Consumer Staples 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELS icon
126
Equity Lifestyle Properties
ELS
$12.6B
$11M 0.07%
156,254
+3,802
+2% +$259K
ROP icon
127
Roper Technologies
ROP
$39.8B
$10.8M 0.07%
19,863
+367
+2% +$189K
NVS icon
128
Novartis
NVS
$297B
$10.5M 0.06%
103,818
-271
-0.3% -$26.2K
PAG icon
129
Penske Automotive Group
PAG
$14.2B
$10.1M 0.06%
62,867
+1,462
+2% +$224K
DOV icon
130
Dover
DOV
$28.4B
$9.84M 0.06%
63,978
-1,210
-2% -$170K
V icon
131
Visa
V
$677B
$9.68M 0.06%
37,189
+478
+1% +$118K
FISV
132
Fiserv Inc
FISV
$27.9B
$9.41M 0.06%
70,830
-408
-0.6% -$50.1K
USPH icon
133
US Physical Therapy
USPH
$1.22B
$9.34M 0.06%
100,315
+49,013
+96% +$4.32M
CHE icon
134
Chemed
CHE
$7.22B
$9.03M 0.05%
15,438
+400
+3% +$224K
ENSG icon
135
The Ensign Group
ENSG
$10.7B
$8.87M 0.05%
79,046
+2,091
+3% +$216K
GOOG icon
136
Alphabet (Google) Class C
GOOG
$4.32T
$8.23M 0.05%
58,405
-1,126
-2% -$153K
DIS icon
137
Walt Disney
DIS
$181B
$8.1M 0.05%
89,733
-3,562
-4% -$314K
PAGP icon
138
Plains GP Holdings
PAGP
$4.9B
$8.05M 0.05%
504,436
+20,382
+4% +$322K
AJG icon
139
Arthur J. Gallagher & Co
AJG
$63.6B
$7.89M 0.05%
35,067
-400
-1% -$94.7K
RMD icon
140
ResMed
RMD
$30.7B
$7.34M 0.04%
42,675
-582
-1% -$89.4K
GOOGL icon
141
Alphabet (Google) Class A
GOOGL
$4.33T
$7.25M 0.04%
51,909
+470
+0.9% +$63.1K
SON icon
142
Sonoco
SON
$5.74B
$7.2M 0.04%
128,848
+1,658
+1% +$89.9K
LMAT icon
143
LeMaitre Vascular
LMAT
$1.86B
$7.13M 0.04%
125,599
+5,207
+4% +$273K
VEU icon
144
Vanguard FTSE All-World ex-US ETF
VEU
$68.5B
$6.95M 0.04%
123,768
+1,691
+1% +$89.6K
FSS icon
145
Federal Signal
FSS
$7.83B
$6.89M 0.04%
89,833
+1,064
+1% +$70.9K
BCPC
146
Balchem Corp
BCPC
$5.72B
$6.85M 0.04%
46,058
+1,143
+3% +$146K
CW icon
147
Curtiss-Wright
CW
$25.5B
$6.74M 0.04%
30,273
+755
+3% +$158K
UFPI icon
148
UFP Industries
UFPI
$5.19B
$6.43M 0.04%
51,185
+576
+1% +$62.2K
TTEK icon
149
Tetra Tech
TTEK
$9.07B
$6.4M 0.04%
191,730
+2,405
+1% +$76.8K
ZTS icon
150
Zoetis
ZTS
$30B
$6.39M 0.04%
32,355
-477
-1% -$84.4K

Similar funds

Bahl & Gaynor's Q4 2023 Portfolio in Review

As of Q4 2023, Bahl & Gaynor held 337 positions worth $16.6B, up 6.2% from $15.7B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bahl & Gaynor's Q4 2023 filing shows 11 new, 98 increased, 190 reduced and 11 closed positions. Its largest new stake was Dell: 520,900 shares worth $39.8M. The largest sale was Medtronic, an estimated $49.2M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q4 2023 buy was Dell: 520,900 shares worth $39.8M.
  • Bahl & Gaynor added most to Amgen in Q4 2023, an estimated $43.9M increase.
  • Bahl & Gaynor's biggest Q4 2023 reduction was Medtronic, cutting an estimated $49.2M.
  • Bahl & Gaynor fully exited SBA Communications in Q4 2023, selling an estimated $375K.
  • Bahl & Gaynor's ten largest holdings make up 31% of its $16.6B portfolio in Q4 2023.
  • Bahl & Gaynor opened 11 new positions and closed 11 in Q4 2023.
  • Bahl & Gaynor's portfolio value rose 6.2% quarter-over-quarter to $16.6B.

Based on Bahl & Gaynor's 13F filing for Q4 2023, filed 2 Feb 2024.